Chargement en cours...
Clinical management of recurrent retinopathy of prematurity following intravitreal bevacizumab monotherapy
PURPOSE: To determine (1) incidence, (2) risk factors, (3) risk period, and (4) characteristics of recurrent retinopathy of prematurity (ROP) treated by intravitreal bevacizumab (IVB) monotherapy. DESIGN: Retrospective case series. PARTICIPANTS: Premature infants developing Type 1 ROP [subdivided in...
Enregistré dans:
| Publié dans: | Ophthalmology |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995132/ https://ncbi.nlm.nih.gov/pubmed/27241619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.04.028 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|